Matthew C Kapusta
CIK 1536290 · CEO, Managing Director · last filed 2026-07-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$20.62M
Companies
3
Total Filings
92
Lifetime Open-Market Net
-$50.17M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QURE | CEO, Managing Director | 519,227 | $39.71 | $20.62M | -$50.18M | 69 | 2026-07-07 |
| Decibel Therapeutics, Inc. (DBTX) Delisted | Director | 0 | $4.91 | $0 | $0 | 2 | 2023-09-25 |
| ANGIODYNAMICS INC (ANGO.V) Delisted | SVP, Business Development | 30,062 | — | — | $11.4K | 11 | 2014-11-19 |
Recent Filings · Page 3 of 10
92 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-05 | QURE | Grant (A) | +150,000 | $0 | EDGAR |
| 2024-02-28 | QURE | Sell (S) | −27,904 | -$177.2K | EDGAR |
| 2024-02-26 | QURE | Notice (144) | −27,904 | -$180.5K | EDGAR |
| 2023-09-25 | Decibel Therapeutics, Inc. (DBTX) Delisted | Disp (D) | −10,000 | $0 | EDGAR |
| 2023-03-21 | Decibel Therapeutics, Inc. (DBTX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2023-03-09 | QURE | Sell (S) | −2,521 | -$53.9K | EDGAR |
| 2023-03-01 | QURE | Sell (S) | −24,547 | -$493.3K | EDGAR |
| 2023-02-27 | QURE | Grant (A) | +121,500 | $0 | EDGAR |
| 2023-02-22 | QURE | Grant (A) | +5,830 | $0 | EDGAR |
| 2022-12-13 | QURE | Sell (S) | −6,648 | -$149.2K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.